(1996) multiple physiological functions for insulin- like growth factors. ,

(1996) Wild- type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene,

(1995) Insulin-like growth factors^their binding proteins : biological actions,

(1995) Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action,

(1997) In^#56194^sulin-like growth factor 1 alters drug sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. ,

(1998) Regulation of insulin- like growth factor II and IGF binding protein-3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,

(1997) . Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product,

(1996) Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780, Clin Cancer Res

(1999) Bicalutamide(Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins,

gative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci U S A 1994,

(1998) Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation,

(1996) Rosenfeld RG. Insulin- like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. ,

(2001) activates the human IGF binding protein-3 promoter in breast cancer cells molecular mechanism involves an Sp1/Sp3 multiprotein complex,

(1858-66.) and retinoic acid modulation of IGF-binding proteins and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 1992,

(2002) Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer, Clin Cancer Res

(1995) et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. ,

(1992) Prostate-specific antigen(PSA)is an insulin-like growth factor binding protein-3 protease found in seminal plasma,

(1994) Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells:role of cathepsin D,

(1994) Insulin-like growth factor-I comparisons in healthy twin children,

(2001) Novel promoter polymorphism in insulin-like growth factor-binding protein-3:correlation with serum levels and interaction with known regulators,

(1996) onmental components of interindividual variation in circulating levels of IGF-I,

(2003) Polymorphic variation at the -202 locus in IGFBP3 influence on serum levels of insulin-like growth factors interaction with plasma retinol and vitamin D and breast cancer risk,

(1998) Plasma insulin-like growth factor-I and prostate cancer risk:a prospective study,

(1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer,

(2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer:a systematic review,

(2004) Genetic polymorphisms in the IGFBP3 gene:association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women,

(1999) Prospetive study of colorectal cancer risk in men and plasma levels of insulin-like growth factor(IGF)-1 and IGF-binding protein-3,

(1999) Plasma levels of insulin-like growth factor-I and lung cancer risk:a case-control analysis,

(2003) Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer,

(1994) Insulin-like growth factor- binding protein enhancement of insulin-like growth factor-I(IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line,

(1988) Growth hormone-dependent insulin-like growth factor(IGF)binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts,

(2003) Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis,

(1999) Changes of the insulin-like growth factor I system during acute myocardial infarction implications on left ventricular remodeling,

(1999) Evaluation of the components of in system in adolescents with type 1 diabetes and persistent microalbuminuria relationship with increased urinary excretion of IGFBP-3 18kD N-terminal fragment,

(2003) Trophic factors and cytokines in early diabetic glomerulopathy,

(2000) Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy,